speb/financial-data huggingface dataset:
CNO cash_flow (quarterly, 2025-09-30) — Gain Loss On Investment Securities: 15400000.00
CNO balance_sheet (quarterly, 2025-09-30) — Gains Losses Not Affecting Retained Earnings: -1118900000.00
CNO income_statement (quarterly, 2025-09-30) — Impairment Of Capital Assets: 96700000.00
CNO income_statement (quarterly, 2025-09-30) — Interest Expense: 56600000.00
CNO income_statement (quarterly, 2025-09-30) — Interest Expense Non Operating: 56600000.00
CNO balance_sheet (quarterly, 2025-09-30) — Invested Capital: 6662200000.00
CNO cash_flow (quarterly, 2025-09-30) — Investing Cash Flow: -106100000.00
CNO balance_sheet (quarterly, 2025-09-30) — Investments And Advances: 24376200000.00
CNO balance_sheet (quarterly, 2025-09-30) — Investments In Other Ventures Under Equity Method: 296800000.00
CNO cash_flow (quarterly, 2025-09-30) — Issuance Of Capital Stock: 2500000.00
CNO cash_flow (quarterly, 2025-09-30) — Issuance Of Debt: 250000000.00
CNO balance_sheet (quarterly, 2025-09-30) — Long Term Debt: 4051200000.00
CNO balance_sheet (quarterly, 2025-09-30) — Long Term Debt And Capital Lease Obligation: 4051200000.00
CNO cash_flow (quarterly, 2025-09-30) — Long Term Debt Issuance: 250000000.00
CNO cash_flow (quarterly, 2025-09-30) — Long Term Debt Payments: -328700000.00
CNO balance_sheet (quarterly, 2025-09-30) — Long Term Equity Investment: 296800000.00
CNO income_statement (quarterly, 2025-09-30) — Loss Adjustment Expense: 658900000.00
CNO cash_flow (quarterly, 2025-09-30) — Net Common Stock Issuance: -58100000.00
CNO balance_sheet (quarterly, 2025-09-30) — Net Debt: 2832900000.00
CNO income_statement (quarterly, 2025-09-30) — Net Income: 23100000.00
CNO income_statement (quarterly, 2025-09-30) — Net Income Common Stockholders: 23100000.00
CNO income_statement (quarterly, 2025-09-30) — Net Income Continuous Operations: 23100000.00
CNO income_statement (quarterly, 2025-09-30) — Net Income From Continuing And Discontinued Operation: 23100000.00
CNO income_statement (quarterly, 2025-09-30) — Net Income From Continuing Operation Net Minority Interest: 23100000.00
CNO cash_flow (quarterly, 2025-09-30) — Net Income From Continuing Operations: 23100000.00
CNO income_statement (quarterly, 2025-09-30) — Net Income Including Noncontrolling Interests: 23100000.00
CNO income_statement (quarterly, 2025-09-30) — Net Interest Income: -56600000.00
CNO cash_flow (quarterly, 2025-09-30) — Net Investment Purchase And Sale: -116200000.00
CNO cash_flow (quarterly, 2025-09-30) — Net Issuance Payments Of Debt: -78700000.00
CNO cash_flow (quarterly, 2025-09-30) — Net Long Term Debt Issuance: -78700000.00
CNO income_statement (quarterly, 2025-09-30) — Net Non Operating Interest Income Expense: -56600000.00
CNO cash_flow (quarterly, 2025-09-30) — Net Other Financing Charges: 487100000.00
CNO cash_flow (quarterly, 2025-09-30) — Net Other Investing Changes: 10100000.00
CNO income_statement (quarterly, 2025-09-30) — Net Policyholder Benefits And Claims: 658900000.00
CNO balance_sheet (quarterly, 2025-09-30) — Net Tangible Assets: 2611000000.00
CNO income_statement (quarterly, 2025-09-30) — Normalized Income: 84806353.59
CNO cash_flow (quarterly, 2025-09-30) — Operating Cash Flow: 197800000.00
CNO cash_flow (quarterly, 2025-09-30) — Operating Gains Losses: 15400000.00
CNO income_statement (quarterly, 2025-09-30) — Operating Revenue: 1188700000.00
CNO balance_sheet (quarterly, 2025-09-30) — Ordinary Shares Number: 95840989.00
CNO balance_sheet (quarterly, 2025-09-30) — Other Equity Adjustments: -1118900000.00
CNO cash_flow (quarterly, 2025-09-30) — Other Non Cash Items: -71600000.00
CNO income_statement (quarterly, 2025-09-30) — Other Operating Expenses: 270400000.00
CNO balance_sheet (quarterly, 2025-09-30) — Other Short Term Investments: 7380600000.00
CNO income_statement (quarterly, 2025-09-30) — Pretax Income: 36200000.00
CNO cash_flow (quarterly, 2025-09-30) — Purchase Of Investment: -1661100000.00
CNO balance_sheet (quarterly, 2025-09-30) — Receivables: 4439800000.00
CNO income_statement (quarterly, 2025-09-30) — Reconciled Depreciation: 80100000.00
CNO cash_flow (quarterly, 2025-09-30) — Repayment Of Debt: -328700000.00
CNO cash_flow (quarterly, 2025-09-30) — Repurchase Of Capital Stock: -60600000.00
CNO balance_sheet (quarterly, 2025-09-30) — Retained Earnings: 2339500000.00
CNO cash_flow (quarterly, 2025-09-30) — Sale Of Investment: 1544900000.00
CNO balance_sheet (quarterly, 2025-09-30) — Share Issued: 95840989.00
CNO income_statement (quarterly, 2025-09-30) — Special Income Charges: -96700000.00
CNO balance_sheet (quarterly, 2025-09-30) — Stockholders Equity: 2611000000.00
CNO balance_sheet (quarterly, 2025-09-30) — Tangible Book Value: 2611000000.00
CNO income_statement (quarterly, 2025-09-30) — Tax Effect Of Unusual Items: -34993646.41
CNO income_statement (quarterly, 2025-09-30) — Tax Provision: 13100000.00
CNO income_statement (quarterly, 2025-09-30) — Tax Rate For Calcs: 0.36
CNO balance_sheet (quarterly, 2025-09-30) — Taxes Receivable: 708100000.00
CNO balance_sheet (quarterly, 2025-09-30) — Total Assets: 38296200000.00
CNO balance_sheet (quarterly, 2025-09-30) — Total Capitalization: 6662200000.00
CNO balance_sheet (quarterly, 2025-09-30) — Total Debt: 4051200000.00
CNO balance_sheet (quarterly, 2025-09-30) — Total Equity Gross Minority Interest: 2611000000.00
CNO income_statement (quarterly, 2025-09-30) — Total Expenses: 1152500000.00
CNO balance_sheet (quarterly, 2025-09-30) — Total Liabilities Net Minority Interest: 35685200000.00
CNO income_statement (quarterly, 2025-09-30) — Total Unusual Items: -96700000.00
CNO income_statement (quarterly, 2025-09-30) — Total Unusual Items Excluding Goodwill: -96700000.00
CNO income_statement (annual, 2025-12-31) — +Total Revenue: 4487400000.00
CNO income_statement (quarterly, 2025-12-31) — +Total Revenue: 1143100000.00
CNO balance_sheet (annual, 2025-12-31) — Accounts Receivable: 3677500000.00
CNO balance_sheet (quarterly, 2025-12-31) — Accounts Receivable: 3677500000.00
CNO balance_sheet (annual, 2025-12-31) — Additional Paid In Capital: 1336300000.00
CNO balance_sheet (quarterly, 2025-12-31) — Additional Paid In Capital: 1336300000.00
CNO cash_flow (annual, 2025-12-31) — Amortization Of Securities: -499300000.00
CNO cash_flow (quarterly, 2025-12-31) — Amortization Of Securities: -121500000.00
CNO cash_flow (annual, 2025-12-31) — Asset Impairment Charge: 101900000.00
CNO cash_flow (quarterly, 2025-12-31) — Asset Impairment Charge: 5200000.00
CNO income_statement (annual, 2025-12-31) — Basic Average Shares: 97763000.00
CNO income_statement (quarterly, 2025-12-31) — Basic Average Shares: 95136000.00
CNO income_statement (annual, 2025-12-31) — Basic EPS: 2.35
CNO income_statement (quarterly, 2025-12-31) — Basic EPS: 0.98
CNO cash_flow (annual, 2025-12-31) — Beginning Cash Position: 1997700000.00
CNO cash_flow (quarterly, 2025-12-31) — Beginning Cash Position: 1241600000.00
CNO balance_sheet (annual, 2025-12-31) — Capital Stock: 900000.00
CNO balance_sheet (quarterly, 2025-12-31) — Capital Stock: 900000.00
CNO balance_sheet (annual, 2025-12-31) — Cash And Cash Equivalents: 956100000.00
CNO balance_sheet (quarterly, 2025-12-31) — Cash And Cash Equivalents: 956100000.00
CNO balance_sheet (annual, 2025-12-31) — Cash Cash Equivalents And Short Term Investments: 8578300000.00
CNO balance_sheet (quarterly, 2025-12-31) — Cash Cash Equivalents And Short Term Investments: 8578300000.00
CNO cash_flow (annual, 2025-12-31) — Cash Dividends Paid: -66200000.00
CNO cash_flow (quarterly, 2025-12-31) — Cash Dividends Paid: -16200000.00
CNO cash_flow (annual, 2025-12-31) — Cash Flow From Continuing Financing Activities: -22600000.00
CNO cash_flow (quarterly, 2025-12-31) — Cash Flow From Continuing Financing Activities: 447000000.00
CNO cash_flow (annual, 2025-12-31) — Cash Flow From Continuing Investing Activities: -1667300000.00
CNO cash_flow (quarterly, 2025-12-31) — Cash Flow From Continuing Investing Activities: -900800000.00
CNO cash_flow (annual, 2025-12-31) — Cash Flow From Continuing Operating Activities: 675700000.00
CNO cash_flow (quarterly, 2025-12-31) — Cash Flow From Continuing Operating Activities: 195700000.00
CNO cash_flow (annual, 2025-12-31) — Change In Working Capital: 618100000.00
CNO cash_flow (quarterly, 2025-12-31) — Change In Working Capital: 156700000.00
CNO cash_flow (annual, 2025-12-31) — Changes In Cash: -1014200000.00
CNO cash_flow (quarterly, 2025-12-31) — Changes In Cash: -258100000.00
CNO balance_sheet (annual, 2025-12-31) — Common Stock: 900000.00
CNO balance_sheet (quarterly, 2025-12-31) — Common Stock: 900000.00
CNO cash_flow (annual, 2025-12-31) — Common Stock Dividend Paid: -66200000.00
CNO cash_flow (quarterly, 2025-12-31) — Common Stock Dividend Paid: -16200000.00
CNO balance_sheet (annual, 2025-12-31) — Common Stock Equity: 2638200000.00
CNO balance_sheet (quarterly, 2025-12-31) — Common Stock Equity: 2638200000.00
CNO cash_flow (annual, 2025-12-31) — Common Stock Issuance: 11600000.00
CNO cash_flow (quarterly, 2025-12-31) — Common Stock Issuance: 2000000.00
CNO cash_flow (annual, 2025-12-31) — Common Stock Payments: -331400000.00
CNO cash_flow (quarterly, 2025-12-31) — Common Stock Payments: -60200000.00
CNO cash_flow (annual, 2025-12-31) — Deferred Income Tax: 26300000.00
CNO cash_flow (quarterly, 2025-12-31) — Deferred Income Tax: -9800000.00
CNO cash_flow (annual, 2025-12-31) — Deferred Tax: 26300000.00
CNO cash_flow (quarterly, 2025-12-31) — Deferred Tax: -9800000.00
CNO cash_flow (annual, 2025-12-31) — Depreciation And Amortization: 318500000.00
CNO cash_flow (quarterly, 2025-12-31) — Depreciation And Amortization: 81800000.00
CNO income_statement (annual, 2025-12-31) — Diluted Average Shares: 99822000.00
CNO income_statement (quarterly, 2025-12-31) — Diluted Average Shares: 97278000.00
CNO income_statement (annual, 2025-12-31) — Diluted EPS: 2.30
CNO income_statement (quarterly, 2025-12-31) — Diluted EPS: 0.95
CNO income_statement (annual, 2025-12-31) — Diluted NI Availto Com Stockholders: 229300000.00
CNO income_statement (quarterly, 2025-12-31) — Diluted NI Availto Com Stockholders: 92900000.00
CNO income_statement (annual, 2025-12-31) — EBIT: 524300000.00
CNO income_statement (quarterly, 2025-12-31) — EBIT: 164600000.00
CNO cash_flow (annual, 2025-12-31) — End Cash Position: 983500000.00
CNO cash_flow (quarterly, 2025-12-31) — End Cash Position: 983500000.00
CNO cash_flow (annual, 2025-12-31) — Financing Cash Flow: -22600000.00
CNO cash_flow (quarterly, 2025-12-31) — Financing Cash Flow: 447000000.00
CNO cash_flow (annual, 2025-12-31) — Free Cash Flow: 675700000.00
CNO cash_flow (quarterly, 2025-12-31) — Free Cash Flow: 195700000.00
CNO cash_flow (annual, 2025-12-31) — Gain Loss On Investment Securities: 54700000.00
CNO cash_flow (quarterly, 2025-12-31) — Gain Loss On Investment Securities: 14100000.00
CNO balance_sheet (annual, 2025-12-31) — Gains Losses Not Affecting Retained Earnings: -1115000000.00
CNO balance_sheet (quarterly, 2025-12-31) — Gains Losses Not Affecting Retained Earnings: -1115000000.00
CNO income_statement (annual, 2025-12-31) — General And Administrative Expense: 305000000.00
CNO income_statement (annual, 2025-12-31) — Impairment Of Capital Assets: 101900000.00
CNO income_statement (quarterly, 2025-12-31) — Impairment Of Capital Assets: 5200000.00
CNO income_statement (annual, 2025-12-31) — Interest Expense: 230900000.00
CNO income_statement (quarterly, 2025-12-31) — Interest Expense: 53200000.00
CNO income_statement (annual, 2025-12-31) — Interest Expense Non Operating: 230900000.00
CNO income_statement (quarterly, 2025-12-31) — Interest Expense Non Operating: 53200000.00
CNO balance_sheet (annual, 2025-12-31) — Invested Capital: 6689900000.00
CNO balance_sheet (quarterly, 2025-12-31) — Invested Capital: 6689900000.00
CNO cash_flow (annual, 2025-12-31) — Investing Cash Flow: -1667300000.00
CNO cash_flow (quarterly, 2025-12-31) — Investing Cash Flow: -900800000.00
CNO balance_sheet (annual, 2025-12-31) — Investments And Advances: 24863800000.00
CNO balance_sheet (quarterly, 2025-12-31) — Investments And Advances: 24863800000.00
CNO balance_sheet (annual, 2025-12-31) — Investments In Other Ventures Under Equity Method: 293000000.00
CNO balance_sheet (quarterly, 2025-12-31) — Investments In Other Ventures Under Equity Method: 293000000.00
CNO cash_flow (annual, 2025-12-31) — Issuance Of Capital Stock: 11600000.00
CNO cash_flow (quarterly, 2025-12-31) — Issuance Of Capital Stock: 2000000.00
CNO cash_flow (annual, 2025-12-31) — Issuance Of Debt: 776800000.00
CNO cash_flow (quarterly, 2025-12-31) — Issuance Of Debt: 0.00
CNO balance_sheet (annual, 2025-12-31) — Long Term Debt: 4051700000.00
CNO balance_sheet (quarterly, 2025-12-31) — Long Term Debt: 4051700000.00
CNO balance_sheet (annual, 2025-12-31) — Long Term Debt And Capital Lease Obligation: 4051700000.00
CNO balance_sheet (quarterly, 2025-12-31) — Long Term Debt And Capital Lease Obligation: 4051700000.00
CNO cash_flow (annual, 2025-12-31) — Long Term Debt Issuance: 776800000.00
CNO cash_flow (quarterly, 2025-12-31) — Long Term Debt Issuance: 0.00
CNO cash_flow (annual, 2025-12-31) — Long Term Debt Payments: -1261800000.00
CNO cash_flow (quarterly, 2025-12-31) — Long Term Debt Payments: -15500000.00
CNO balance_sheet (annual, 2025-12-31) — Long Term Equity Investment: 293000000.00
CNO balance_sheet (quarterly, 2025-12-31) — Long Term Equity Investment: 293000000.00
CNO income_statement (annual, 2025-12-31) — Loss Adjustment Expense: 2465100000.00
CNO income_statement (quarterly, 2025-12-31) — Loss Adjustment Expense: 598400000.00
CNO cash_flow (annual, 2025-12-31) — Net Common Stock Issuance: -319800000.00
CNO cash_flow (quarterly, 2025-12-31) — Net Common Stock Issuance: -58200000.00
CNO balance_sheet (annual, 2025-12-31) — Net Debt: 3095600000.00
CNO balance_sheet (quarterly, 2025-12-31) — Net Debt: 3095600000.00
CNO income_statement (annual, 2025-12-31) — Net Income: 229300000.00
CNO income_statement (quarterly, 2025-12-31) — Net Income: 92900000.00
CNO income_statement (annual, 2025-12-31) — Net Income Common Stockholders: 229300000.00
CNO income_statement (quarterly, 2025-12-31) — Net Income Common Stockholders: 92900000.00
CNO income_statement (annual, 2025-12-31) — Net Income Continuous Operations: 229300000.00
CNO income_statement (quarterly, 2025-12-31) — Net Income Continuous Operations: 92900000.00
CNO income_statement (annual, 2025-12-31) — Net Income From Continuing And Discontinued Operation: 229300000.00
CNO income_statement (quarterly, 2025-12-31) — Net Income From Continuing And Discontinued Operation: 92900000.00
CNO income_statement (annual, 2025-12-31) — Net Income From Continuing Operation Net Minority Interest: 229300000.00
CNO income_statement (quarterly, 2025-12-31) — Net Income From Continuing Operation Net Minority Interest: 92900000.00
CNO cash_flow (annual, 2025-12-31) — Net Income From Continuing Operations: 229300000.00
CNO cash_flow (quarterly, 2025-12-31) — Net Income From Continuing Operations: 92900000.00
CNO income_statement (annual, 2025-12-31) — Net Income Including Noncontrolling Interests: 229300000.00
CNO income_statement (quarterly, 2025-12-31) — Net Income Including Noncontrolling Interests: 92900000.00
CNO income_statement (annual, 2025-12-31) — Net Interest Income: -230900000.00
CNO income_statement (quarterly, 2025-12-31) — Net Interest Income: -53200000.00
CNO cash_flow (annual, 2025-12-31) — Net Investment Purchase And Sale: -1664100000.00
CNO cash_flow (quarterly, 2025-12-31) — Net Investment Purchase And Sale: -896700000.00
CNO cash_flow (annual, 2025-12-31) — Net Issuance Payments Of Debt: -485000000.00
CNO cash_flow (quarterly, 2025-12-31) — Net Issuance Payments Of Debt: -15500000.00
CNO cash_flow (annual, 2025-12-31) — Net Long Term Debt Issuance: -485000000.00
CNO cash_flow (quarterly, 2025-12-31) — Net Long Term Debt Issuance: -15500000.00
CNO income_statement (annual, 2025-12-31) — Net Non Operating Interest Income Expense: -230900000.00
CNO income_statement (quarterly, 2025-12-31) — Net Non Operating Interest Income Expense: -53200000.00
CNO cash_flow (annual, 2025-12-31) — Net Other Financing Charges: 848400000.00
CNO cash_flow (quarterly, 2025-12-31) — Net Other Financing Charges: 536900000.00
CNO cash_flow (annual, 2025-12-31) — Net Other Investing Changes: -3200000.00
CNO cash_flow (quarterly, 2025-12-31) — Net Other Investing Changes: -4100000.00
CNO income_statement (annual, 2025-12-31) — Net Policyholder Benefits And Claims: 2465100000.00
CNO income_statement (quarterly, 2025-12-31) — Net Policyholder Benefits And Claims: 598400000.00
CNO balance_sheet (annual, 2025-12-31) — Net Tangible Assets: 2638200000.00
CNO balance_sheet (quarterly, 2025-12-31) — Net Tangible Assets: 2638200000.00
CNO income_statement (annual, 2025-12-31) — Normalized Income: 307712400.00
CNO income_statement (quarterly, 2025-12-31) — Normalized Income: 97236445.24
CNO cash_flow (annual, 2025-12-31) — Operating Cash Flow: 675700000.00
CNO cash_flow (quarterly, 2025-12-31) — Operating Cash Flow: 195700000.00
CNO cash_flow (annual, 2025-12-31) — Operating Gains Losses: 54700000.00
CNO cash_flow (quarterly, 2025-12-31) — Operating Gains Losses: 14100000.00
CNO income_statement (annual, 2025-12-31) — Operating Revenue: 4487400000.00
CNO income_statement (quarterly, 2025-12-31) — Operating Revenue: 1143100000.00
CNO balance_sheet (annual, 2025-12-31) — Ordinary Shares Number: 94484339.00
CNO balance_sheet (quarterly, 2025-12-31) — Ordinary Shares Number: 94484339.00
CNO balance_sheet (annual, 2025-12-31) — Other Equity Adjustments: -1115000000.00
CNO balance_sheet (quarterly, 2025-12-31) — Other Equity Adjustments: -1115000000.00
CNO cash_flow (annual, 2025-12-31) — Other Non Cash Items: -173800000.00
CNO cash_flow (quarterly, 2025-12-31) — Other Non Cash Items: -36100000.00
CNO income_statement (annual, 2025-12-31) — Other Operating Expenses: 680000000.00
CNO income_statement (quarterly, 2025-12-31) — Other Operating Expenses: -136800000.00
CNO balance_sheet (annual, 2025-12-31) — Other Short Term Investments: 7622200000.00
CNO balance_sheet (quarterly, 2025-12-31) — Other Short Term Investments: 7622200000.00
CNO income_statement (annual, 2025-12-31) — Other Special Charges: -1500000.00
CNO income_statement (quarterly, 2025-12-31) — Other Special Charges: 0.00
CNO income_statement (annual, 2025-12-31) — Pretax Income: 293400000.00
CNO income_statement (quarterly, 2025-12-31) — Pretax Income: 111400000.00
CNO cash_flow (annual, 2025-12-31) — Purchase Of Investment: -8459500000.00
CNO cash_flow (quarterly, 2025-12-31) — Purchase Of Investment: -3167200000.00
CNO balance_sheet (annual, 2025-12-31) — Receivables: 4390800000.00
CNO balance_sheet (quarterly, 2025-12-31) — Receivables: 4390800000.00
CNO income_statement (annual, 2025-12-31) — Reconciled Depreciation: 318500000.00
CNO income_statement (quarterly, 2025-12-31) — Reconciled Depreciation: 81800000.00
CNO cash_flow (annual, 2025-12-31) — Repayment Of Debt: -1261800000.00
CNO cash_flow (quarterly, 2025-12-31) — Repayment Of Debt: -15500000.00
CNO cash_flow (annual, 2025-12-31) — Repurchase Of Capital Stock: -331400000.00
CNO cash_flow (quarterly, 2025-12-31) — Repurchase Of Capital Stock: -60200000.00
CNO balance_sheet (annual, 2025-12-31) — Retained Earnings: 2416000000.00
CNO balance_sheet (quarterly, 2025-12-31) — Retained Earnings: 2416000000.00
CNO income_statement (annual, 2025-12-31) — Salaries And Wages: 305000000.00
CNO cash_flow (annual, 2025-12-31) — Sale Of Investment: 6795400000.00
CNO cash_flow (quarterly, 2025-12-31) — Sale Of Investment: 2270500000.00
CNO income_statement (annual, 2025-12-31) — Selling General And Administration: 305000000.00
CNO balance_sheet (annual, 2025-12-31) — Share Issued: 94484339.00
CNO balance_sheet (quarterly, 2025-12-31) — Share Issued: 94484339.00
CNO income_statement (annual, 2025-12-31) — Special Income Charges: -100400000.00
CNO income_statement (quarterly, 2025-12-31) — Special Income Charges: -5200000.00
CNO balance_sheet (annual, 2025-12-31) — Stockholders Equity: 2638200000.00
CNO balance_sheet (quarterly, 2025-12-31) — Stockholders Equity: 2638200000.00
CNO balance_sheet (annual, 2025-12-31) — Tangible Book Value: 2638200000.00
CNO balance_sheet (quarterly, 2025-12-31) — Tangible Book Value: 2638200000.00
CNO income_statement (annual, 2025-12-31) — Tax Effect Of Unusual Items: -21987600.00
CNO income_statement (quarterly, 2025-12-31) — Tax Effect Of Unusual Items: -863554.76
CNO income_statement (annual, 2025-12-31) — Tax Provision: 64100000.00
CNO income_statement (quarterly, 2025-12-31) — Tax Provision: 18500000.00
CNO income_statement (annual, 2025-12-31) — Tax Rate For Calcs: 0.22
CNO income_statement (quarterly, 2025-12-31) — Tax Rate For Calcs: 0.17
CNO balance_sheet (annual, 2025-12-31) — Taxes Receivable: 713300000.00
CNO balance_sheet (quarterly, 2025-12-31) — Taxes Receivable: 713300000.00
CNO balance_sheet (annual, 2025-12-31) — Total Assets: 38790600000.00
CNO balance_sheet (quarterly, 2025-12-31) — Total Assets: 38790600000.00
CNO balance_sheet (annual, 2025-12-31) — Total Capitalization: 6689900000.00
CNO balance_sheet (quarterly, 2025-12-31) — Total Capitalization: 6689900000.00
CNO balance_sheet (annual, 2025-12-31) — Total Debt: 4051700000.00
CNO balance_sheet (quarterly, 2025-12-31) — Total Debt: 4051700000.00
CNO balance_sheet (annual, 2025-12-31) — Total Equity Gross Minority Interest: 2638200000.00
CNO balance_sheet (quarterly, 2025-12-31) — Total Equity Gross Minority Interest: 2638200000.00
CNO income_statement (annual, 2025-12-31) — Total Expenses: 4194000000.00
CNO income_statement (quarterly, 2025-12-31) — Total Expenses: 1031700000.00
CNO balance_sheet (annual, 2025-12-31) — Total Liabilities Net Minority Interest: 36152400000.00
CNO balance_sheet (quarterly, 2025-12-31) — Total Liabilities Net Minority Interest: 36152400000.00
CNO income_statement (annual, 2025-12-31) — Total Unusual Items: -100400000.00
CNO income_statement (quarterly, 2025-12-31) — Total Unusual Items: -5200000.00
CNO income_statement (annual, 2025-12-31) — Total Unusual Items Excluding Goodwill: -100400000.00
CNO income_statement (quarterly, 2025-12-31) — Total Unusual Items Excluding Goodwill: -5200000.00
CNO income_statement (quarterly, 2026-03-31) — +Total Revenue: 1029600000.00
CNO balance_sheet (quarterly, 2026-03-31) — Accounts Receivable: 3611100000.00
CNO balance_sheet (quarterly, 2026-03-31) — Additional Paid In Capital: 1277800000.00
CNO cash_flow (quarterly, 2026-03-31) — Amortization Of Securities: -114100000.00
CNO income_statement (quarterly, 2026-03-31) — Basic Average Shares: 94078000.00
CNO income_statement (quarterly, 2026-03-31) — Basic EPS: 0.40
CNO cash_flow (quarterly, 2026-03-31) — Beginning Cash Position: 983500000.00
CNO balance_sheet (quarterly, 2026-03-31) — Capital Stock: 900000.00
CNO balance_sheet (quarterly, 2026-03-31) — Cash And Cash Equivalents: 1129500000.00
CNO balance_sheet (quarterly, 2026-03-31) — Cash Cash Equivalents And Short Term Investments: 9107800000.00
CNO cash_flow (quarterly, 2026-03-31) — Cash Dividends Paid: -17100000.00
CNO cash_flow (quarterly, 2026-03-31) — Cash Flow From Continuing Financing Activities: 206100000.00
CNO cash_flow (quarterly, 2026-03-31) — Cash Flow From Continuing Investing Activities: -184100000.00
CNO cash_flow (quarterly, 2026-03-31) — Cash Flow From Continuing Operating Activities: 148800000.00
CNO cash_flow (quarterly, 2026-03-31) — Change In Working Capital: 106900000.00
CNO cash_flow (quarterly, 2026-03-31) — Changes In Cash: 170800000.00
CNO balance_sheet (quarterly, 2026-03-31) — Common Stock: 900000.00
CNO cash_flow (quarterly, 2026-03-31) — Common Stock Dividend Paid: -17100000.00
CNO balance_sheet (quarterly, 2026-03-31) — Common Stock Equity: 2498400000.00
CNO cash_flow (quarterly, 2026-03-31) — Common Stock Issuance: 5600000.00
CNO cash_flow (quarterly, 2026-03-31) — Common Stock Payments: -73300000.00
CNO cash_flow (quarterly, 2026-03-31) — Deferred Income Tax: -5200000.00
CNO cash_flow (quarterly, 2026-03-31) — Deferred Tax: -5200000.00
CNO cash_flow (quarterly, 2026-03-31) — Depreciation And Amortization: 83400000.00
CNO income_statement (quarterly, 2026-03-31) — Diluted Average Shares: 96139000.00
CNO income_statement (quarterly, 2026-03-31) — Diluted EPS: 0.39
CNO income_statement (quarterly, 2026-03-31) — Diluted NI Availto Com Stockholders: 37700000.00
CNO income_statement (quarterly, 2026-03-31) — EBIT: 99300000.00
CNO cash_flow (quarterly, 2026-03-31) — End Cash Position: 1154300000.00
CNO cash_flow (quarterly, 2026-03-31) — Financing Cash Flow: 206100000.00
CNO cash_flow (quarterly, 2026-03-31) — Free Cash Flow: 148800000.00
CNO cash_flow (quarterly, 2026-03-31) — Gain Loss On Investment Securities: 17400000.00
CNO balance_sheet (quarterly, 2026-03-31) — Gains Losses Not Affecting Retained Earnings: -1217600000.00
CNO income_statement (quarterly, 2026-03-31) — Interest Expense: 50900000.00
CNO income_statement (quarterly, 2026-03-31) — Interest Expense Non Operating: 50900000.00
CNO balance_sheet (quarterly, 2026-03-31) — Invested Capital: 6800500000.00
CNO cash_flow (quarterly, 2026-03-31) — Investing Cash Flow: -184100000.00
CNO balance_sheet (quarterly, 2026-03-31) — Investments And Advances: 24781500000.00
CNO balance_sheet (quarterly, 2026-03-31) — Investments In Other Ventures Under Equity Method: 287400000.00
CNO cash_flow (quarterly, 2026-03-31) — Issuance Of Capital Stock: 5600000.00
CNO cash_flow (quarterly, 2026-03-31) — Issuance Of Debt: 450000000.00
CNO balance_sheet (quarterly, 2026-03-31) — Long Term Debt: 4302100000.00
CNO balance_sheet (quarterly, 2026-03-31) — Long Term Debt And Capital Lease Obligation: 4302100000.00
CNO cash_flow (quarterly, 2026-03-31) — Long Term Debt Issuance: 450000000.00
CNO cash_flow (quarterly, 2026-03-31) — Long Term Debt Payments: -200000000.00
CNO balance_sheet (quarterly, 2026-03-31) — Long Term Equity Investment: 287400000.00
CNO income_statement (quarterly, 2026-03-31) — Loss Adjustment Expense: 580800000.00
CNO cash_flow (quarterly, 2026-03-31) — Net Common Stock Issuance: -67700000.00
CNO balance_sheet (quarterly, 2026-03-31) — Net Debt: 3172600000.00
CNO income_statement (quarterly, 2026-03-31) — Net Income: 37700000.00
CNO income_statement (quarterly, 2026-03-31) — Net Income Common Stockholders: 37700000.00
CNO income_statement (quarterly, 2026-03-31) — Net Income Continuous Operations: 37700000.00
CNO income_statement (quarterly, 2026-03-31) — Net Income From Continuing And Discontinued Operation: 37700000.00
CNO income_statement (quarterly, 2026-03-31) — Net Income From Continuing Operation Net Minority Interest: 37700000.00
CNO cash_flow (quarterly, 2026-03-31) — Net Income From Continuing Operations: 37700000.00
CNO income_statement (quarterly, 2026-03-31) — Net Income Including Noncontrolling Interests: 37700000.00
CNO income_statement (quarterly, 2026-03-31) — Net Interest Income: -50900000.00
CNO cash_flow (quarterly, 2026-03-31) — Net Investment Purchase And Sale: -179500000.00
CNO cash_flow (quarterly, 2026-03-31) — Net Issuance Payments Of Debt: 250000000.00
CNO cash_flow (quarterly, 2026-03-31) — Net Long Term Debt Issuance: 250000000.00
CNO income_statement (quarterly, 2026-03-31) — Net Non Operating Interest Income Expense: -50900000.00
CNO cash_flow (quarterly, 2026-03-31) — Net Other Financing Charges: 40900000.00
CNO cash_flow (quarterly, 2026-03-31) — Net Other Investing Changes: -4600000.00
CNO income_statement (quarterly, 2026-03-31) — Net Policyholder Benefits And Claims: 580800000.00
CNO balance_sheet (quarterly, 2026-03-31) — Net Tangible Assets: 2498400000.00
CNO income_statement (quarterly, 2026-03-31) — Normalized Income: 37700000.00
CNO cash_flow (quarterly, 2026-03-31) — Operating Cash Flow: 148800000.00
CNO cash_flow (quarterly, 2026-03-31) — Operating Gains Losses: 17400000.00
CNO income_statement (quarterly, 2026-03-31) — Operating Revenue: 1029600000.00
CNO balance_sheet (quarterly, 2026-03-31) — Ordinary Shares Number: 93795306.00
CNO balance_sheet (quarterly, 2026-03-31) — Other Equity Adjustments: -1217600000.00
CNO cash_flow (quarterly, 2026-03-31) — Other Non Cash Items: 17400000.00
CNO income_statement (quarterly, 2026-03-31) — Other Operating Expenses: 275300000.00
CNO balance_sheet (quarterly, 2026-03-31) — Other Short Term Investments: 7978300000.00
CNO income_statement (quarterly, 2026-03-31) — Pretax Income: 48400000.00
CNO cash_flow (quarterly, 2026-03-31) — Purchase Of Investment: -4834200000.00
CNO balance_sheet (quarterly, 2026-03-31) — Receivables: 4360000000.00
CNO income_statement (quarterly, 2026-03-31) — Reconciled Depreciation: 83400000.00
CNO cash_flow (quarterly, 2026-03-31) — Repayment Of Debt: -200000000.00
CNO cash_flow (quarterly, 2026-03-31) — Repurchase Of Capital Stock: -73300000.00
CNO balance_sheet (quarterly, 2026-03-31) — Retained Earnings: 2437300000.00
CNO cash_flow (quarterly, 2026-03-31) — Sale Of Investment: 4654700000.00
CNO balance_sheet (quarterly, 2026-03-31) — Share Issued: 93795306.00
CNO income_statement (quarterly, 2026-03-31) — Special Income Charges: 0.00
CNO balance_sheet (quarterly, 2026-03-31) — Stockholders Equity: 2498400000.00
CNO balance_sheet (quarterly, 2026-03-31) — Tangible Book Value: 2498400000.00
CNO income_statement (quarterly, 2026-03-31) — Tax Effect Of Unusual Items: 0.00
CNO income_statement (quarterly, 2026-03-31) — Tax Provision: 10700000.00
CNO income_statement (quarterly, 2026-03-31) — Tax Rate For Calcs: 0.22
CNO balance_sheet (quarterly, 2026-03-31) — Taxes Receivable: 748900000.00
CNO balance_sheet (quarterly, 2026-03-31) — Total Assets: 38963400000.00
CNO balance_sheet (quarterly, 2026-03-31) — Total Capitalization: 6800500000.00
CNO balance_sheet (quarterly, 2026-03-31) — Total Debt: 4302100000.00
CNO balance_sheet (quarterly, 2026-03-31) — Total Equity Gross Minority Interest: 2498400000.00
CNO income_statement (quarterly, 2026-03-31) — Total Expenses: 981200000.00
CNO balance_sheet (quarterly, 2026-03-31) — Total Liabilities Net Minority Interest: 36465000000.00
CNO income_statement (quarterly, 2026-03-31) — Total Unusual Items: 0.00
CNO income_statement (quarterly, 2026-03-31) — Total Unusual Items Excluding Goodwill: 0.00
CNO cash_flow (quarterly, 2026-03-31) — Unrealized Gain Loss On Investment Securities: 5300000.00
CNOB cash_flow (annual, 2021-12-31) — Gain Loss On Sale Of Business: -674000.00
CNOB income_statement (annual, 2021-12-31) — Gain On Sale Of Business: 674000.00
CNOB cash_flow (annual, 2021-12-31) — Issuance Of Capital Stock: 110927000.00
CNOB cash_flow (annual, 2021-12-31) — Net Preferred Stock Issuance: 110927000.00
CNOB income_statement (annual, 2021-12-31) — Other Gand A: 6265000.00
CNOB cash_flow (annual, 2021-12-31) — Preferred Stock Issuance: 110927000.00
CNOB cash_flow (annual, 2021-12-31) — Unrealized Gain Loss On Investment Securities: 373000.00
CNOB income_statement (annual, 2022-12-31) — +Total Revenue: 315362000.00
CNOB balance_sheet (annual, 2022-12-31) — Accounts Receivable: 46062000.00
CNOB balance_sheet (annual, 2022-12-31) — Accumulated Depreciation: -38723000.00
CNOB balance_sheet (annual, 2022-12-31) — Additional Paid In Capital: 30126000.00
CNOB income_statement (annual, 2022-12-31) — Amortization: 1685000.00
CNOB cash_flow (annual, 2022-12-31) — Amortization Cash Flow: 1685000.00
CNOB cash_flow (annual, 2022-12-31) — Amortization Of Intangibles: 1685000.00
CNOB income_statement (annual, 2022-12-31) — Amortization Of Intangibles Income Statement: 1685000.00
CNOB balance_sheet (annual, 2022-12-31) — Available For Sale Securities: 15811000.00
CNOB income_statement (annual, 2022-12-31) — Basic Average Shares: 39331353.00
CNOB income_statement (annual, 2022-12-31) — Basic EPS: 3.03
CNOB cash_flow (annual, 2022-12-31) — Beginning Cash Position: 265536000.00
CNOB balance_sheet (annual, 2022-12-31) — Buildings And Improvements: 9797000.00
CNOB cash_flow (annual, 2022-12-31) — Capital Expenditure: -3301000.00
CNOB balance_sheet (annual, 2022-12-31) — Capital Lease Obligations: 11397000.00
CNOB balance_sheet (annual, 2022-12-31) — Capital Stock: 697873000.00
CNOB balance_sheet (annual, 2022-12-31) — Cash And Cash Equivalents: 268315000.00
CNOB balance_sheet (annual, 2022-12-31) — Cash Cash Equivalents And Federal Funds Sold: 314919000.00
CNOB cash_flow (annual, 2022-12-31) — Cash Dividends Paid: -29465000.00
CNOB balance_sheet (annual, 2022-12-31) — Cash Financial: 61629000.00
CNOB cash_flow (annual, 2022-12-31) — Cash Flow From Continuing Financing Activities: 1369234000.00
CNOB cash_flow (annual, 2022-12-31) — Cash Flow From Continuing Investing Activities: -1543232000.00
CNOB cash_flow (annual, 2022-12-31) — Cash Flow From Continuing Operating Activities: 176777000.00
CNOB cash_flow (annual, 2022-12-31) — Change In Other Current Assets: -12413000.00
CNOB cash_flow (annual, 2022-12-31) — Change In Other Current Liabilities: 48322000.00
CNOB cash_flow (annual, 2022-12-31) — Change In Other Working Capital: -182000.00
CNOB cash_flow (annual, 2022-12-31) — Change In Receivables: -11910000.00
CNOB cash_flow (annual, 2022-12-31) — Change In Working Capital: 23817000.00
CNOB cash_flow (annual, 2022-12-31) — Changes In Account Receivables: -11910000.00
CNOB cash_flow (annual, 2022-12-31) — Changes In Cash: 2779000.00
CNOB balance_sheet (annual, 2022-12-31) — Common Stock: 586946000.00
CNOB cash_flow (annual, 2022-12-31) — Common Stock Dividend Paid: -23428000.00
CNOB balance_sheet (annual, 2022-12-31) — Common Stock Equity: 1067824000.00
CNOB cash_flow (annual, 2022-12-31) — Common Stock Payments: -15260000.00
CNOB balance_sheet (annual, 2022-12-31) — Current Debt: 830000000.00
CNOB balance_sheet (annual, 2022-12-31) — Current Debt And Capital Lease Obligation: 830000000.00
CNOB cash_flow (annual, 2022-12-31) — Deferred Income Tax: -403000.00
CNOB cash_flow (annual, 2022-12-31) — Deferred Tax: -403000.00
CNOB cash_flow (annual, 2022-12-31) — Depreciation: 3863000.00
CNOB cash_flow (annual, 2022-12-31) — Depreciation Amortization Depletion: 5548000.00
CNOB income_statement (annual, 2022-12-31) — Depreciation Amortization Depletion Income Statement: 1685000.00
CNOB cash_flow (annual, 2022-12-31) — Depreciation And Amortization: 5548000.00
CNOB income_statement (annual, 2022-12-31) — Depreciation And Amortization In Income Statement: 1685000.00
CNOB income_statement (annual, 2022-12-31) — Diluted Average Shares: 39592691.00
CNOB income_statement (annual, 2022-12-31) — Diluted EPS: 3.01
CNOB income_statement (annual, 2022-12-31) — Diluted NI Availto Com Stockholders: 118887000.00
CNOB cash_flow (annual, 2022-12-31) — End Cash Position: 268315000.00
CNOB cash_flow (annual, 2022-12-31) — Financing Cash Flow: 1369234000.00
CNOB cash_flow (annual, 2022-12-31) — Free Cash Flow: 173476000.00
CNOB cash_flow (annual, 2022-12-31) — Gain Loss On Investment Securities: 0.00
CNOB cash_flow (annual, 2022-12-31) — Gain Loss On Sale Of Business: 0.00
CNOB cash_flow (annual, 2022-12-31) — Gain Loss On Sale Of PPE: 22000.00
CNOB income_statement (annual, 2022-12-31) — Gain On Sale Of Business: 0.00
CNOB income_statement (annual, 2022-12-31) — Gain On Sale Of Security: -1521000.00
CNOB balance_sheet (annual, 2022-12-31) — Gains Losses Not Affecting Retained Earnings: -32364000.00
CNOB income_statement (annual, 2022-12-31) — General And Administrative Expense: 83598000.00
CNOB balance_sheet (annual, 2022-12-31) — Goodwill: 208372000.00
CNOB balance_sheet (annual, 2022-12-31) — Goodwill And Other Intangible Assets: 215684000.00
CNOB balance_sheet (annual, 2022-12-31) — Gross PPE: 76702000.00
CNOB cash_flow (annual, 2022-12-31) — Income Tax Paid Supplemental Data: 49234000.00
CNOB income_statement (annual, 2022-12-31) — Insurance And Claims: 2881000.00
CNOB income_statement (annual, 2022-12-31) — Interest Expense: 71627000.00
CNOB income_statement (annual, 2022-12-31) — Interest Income: 373746000.00
CNOB cash_flow (annual, 2022-12-31) — Interest Paid Supplemental Data: 67850000.00
CNOB balance_sheet (annual, 2022-12-31) — Invested Capital: 2078701000.00
CNOB cash_flow (annual, 2022-12-31) — Investing Cash Flow: -1543232000.00
CNOB balance_sheet (annual, 2022-12-31) — Investments And Advances: 650695000.00
CNOB cash_flow (annual, 2022-12-31) — Issuance Of Capital Stock: 0.00
CNOB cash_flow (annual, 2022-12-31) — Issuance Of Debt: 4203181000.00
CNOB balance_sheet (annual, 2022-12-31) — Land And Improvements: 6732000.00
CNOB balance_sheet (annual, 2022-12-31) — Leases: 25164000.00
CNOB balance_sheet (annual, 2022-12-31) — Long Term Capital Lease Obligation: 11397000.00
CNOB balance_sheet (annual, 2022-12-31) — Long Term Debt: 180877000.00
CNOB balance_sheet (annual, 2022-12-31) — Long Term Debt And Capital Lease Obligation: 192274000.00
CNOB cash_flow (annual, 2022-12-31) — Long Term Debt Issuance: 4203181000.00
CNOB cash_flow (annual, 2022-12-31) — Long Term Debt Payments: -3813792000.00
CNOB balance_sheet (annual, 2022-12-31) — Machinery Furniture Equipment: 24830000.00
CNOB cash_flow (annual, 2022-12-31) — Net Business Purchase And Sale: 0.00
CNOB cash_flow (annual, 2022-12-31) — Net Common Stock Issuance: -15260000.00
CNOB balance_sheet (annual, 2022-12-31) — Net Debt: 742562000.00
CNOB income_statement (annual, 2022-12-31) — Net Income: 125211000.00
CNOB income_statement (annual, 2022-12-31) — Net Income Common Stockholders: 118887000.00
CNOB income_statement (annual, 2022-12-31) — Net Income Continuous Operations: 125211000.00
CNOB income_statement (annual, 2022-12-31) — Net Income From Continuing And Discontinued Operation: 125211000.00
CNOB income_statement (annual, 2022-12-31) — Net Income From Continuing Operation Net Minority Interest: 125211000.00
CNOB cash_flow (annual, 2022-12-31) — Net Income From Continuing Operations: 125211000.00
CNOB income_statement (annual, 2022-12-31) — Net Income Including Noncontrolling Interests: 125211000.00
CNOB income_statement (annual, 2022-12-31) — Net Interest Income: 302119000.00
CNOB cash_flow (annual, 2022-12-31) — Net Investment Purchase And Sale: -199275000.00
CNOB cash_flow (annual, 2022-12-31) — Net Issuance Payments Of Debt: 389389000.00
CNOB cash_flow (annual, 2022-12-31) — Net Long Term Debt Issuance: 389389000.00
CNOB cash_flow (annual, 2022-12-31) — Net Other Investing Changes: -48469000.00
CNOB balance_sheet (annual, 2022-12-31) — Net PPE: 37979000.00
CNOB cash_flow (annual, 2022-12-31) — Net PPE Purchase And Sale: -2604000.00
CNOB cash_flow (annual, 2022-12-31) — Net Preferred Stock Issuance: 0.00
CNOB balance_sheet (annual, 2022-12-31) — Net Tangible Assets: 963067000.00
CNOB income_statement (annual, 2022-12-31) — Normalized Income: 126319196.00
CNOB income_statement (annual, 2022-12-31) — Occupancy And Equipment: 9865000.00
CNOB cash_flow (annual, 2022-12-31) — Operating Cash Flow: 176777000.00
CNOB cash_flow (annual, 2022-12-31) — Operating Gains Losses: -1673000.00
CNOB income_statement (annual, 2022-12-31) — Operating Revenue: 315362000.00
CNOB balance_sheet (annual, 2022-12-31) — Ordinary Shares Number: 39243123.00
CNOB balance_sheet (annual, 2022-12-31) — Other Current Borrowings: 830000000.00
CNOB balance_sheet (annual, 2022-12-31) — Other Equity Adjustments: -32364000.00
CNOB balance_sheet (annual, 2022-12-31) — Other Intangible Assets: 7312000.00
CNOB cash_flow (annual, 2022-12-31) — Other Non Cash Items: -2038000.00
CNOB income_statement (annual, 2022-12-31) — Other Non Interest Expense: 19979000.00
CNOB balance_sheet (annual, 2022-12-31) — Other Properties: 10179000.00
CNOB balance_sheet (annual, 2022-12-31) — Other Short Term Investments: 634884000.00
CNOB income_statement (annual, 2022-12-31) — Otherunder Preferred Stock Dividend: 287000.00
CNOB balance_sheet (annual, 2022-12-31) — Preferred Shares Number: 4600000.00
CNOB balance_sheet (annual, 2022-12-31) — Preferred Stock: 110927000.00
CNOB cash_flow (annual, 2022-12-31) — Preferred Stock Dividend Paid: -6037000.00
CNOB income_statement (annual, 2022-12-31) — Preferred Stock Dividends: 6037000.00
CNOB balance_sheet (annual, 2022-12-31) — Preferred Stock Equity: 110927000.00
CNOB cash_flow (annual, 2022-12-31) — Preferred Stock Issuance: 0.00
CNOB income_statement (annual, 2022-12-31) — Pretax Income: 171224000.00
CNOB cash_flow (annual, 2022-12-31) — Proceeds From Stock Option Exercised: 124000.00
CNOB income_statement (annual, 2022-12-31) — Professional Expense And Contract Services Expense: 8053000.00
CNOB cash_flow (annual, 2022-12-31) — Purchase Of Investment: -349562000.00
CNOB cash_flow (annual, 2022-12-31) — Purchase Of PPE: -3301000.00
CNOB balance_sheet (annual, 2022-12-31) — Receivables: 46062000.00
CNOB income_statement (annual, 2022-12-31) — Reconciled Depreciation: 5548000.00
CNOB cash_flow (annual, 2022-12-31) — Repayment Of Debt: -3813792000.00
CNOB cash_flow (annual, 2022-12-31) — Repurchase Of Capital Stock: -15260000.00
CNOB income_statement (annual, 2022-12-31) — Restructuring And Mergern Acquisition: 1516000.00
CNOB balance_sheet (annual, 2022-12-31) — Retained Earnings: 535915000.00
CNOB income_statement (annual, 2022-12-31) — Salaries And Wages: 80717000.00
CNOB cash_flow (annual, 2022-12-31) — Sale Of Business: 0.00
CNOB cash_flow (annual, 2022-12-31) — Sale Of Investment: 150287000.00
CNOB cash_flow (annual, 2022-12-31) — Sale Of PPE: 697000.00
CNOB income_statement (annual, 2022-12-31) — Selling And Marketing Expense: 1692000.00
CNOB income_statement (annual, 2022-12-31) — Selling General And Administration: 85290000.00
CNOB balance_sheet (annual, 2022-12-31) — Share Issued: 41942149.00
CNOB income_statement (annual, 2022-12-31) — Special Income Charges: -1516000.00
CNOB cash_flow (annual, 2022-12-31) — Stock Based Compensation: 4889000.00
CNOB balance_sheet (annual, 2022-12-31) — Stockholders Equity: 1178751000.00
CNOB balance_sheet (annual, 2022-12-31) — Tangible Book Value: 852140000.00
CNOB income_statement (annual, 2022-12-31) — Tax Effect Of Unusual Items: -407804.00
CNOB income_statement (annual, 2022-12-31) — Tax Provision: 46013000.00
CNOB income_statement (annual, 2022-12-31) — Tax Rate For Calcs: 0.27
CNOB balance_sheet (annual, 2022-12-31) — Total Assets: 9644948000.00
CNOB balance_sheet (annual, 2022-12-31) — Total Capitalization: 1359628000.00
CNOB balance_sheet (annual, 2022-12-31) — Total Debt: 1022274000.00
CNOB balance_sheet (annual, 2022-12-31) — Total Equity Gross Minority Interest: 1178751000.00
CNOB balance_sheet (annual, 2022-12-31) — Total Liabilities Net Minority Interest: 8466197000.00
CNOB income_statement (annual, 2022-12-31) — Total Unusual Items: -1516000.00
CNOB income_statement (annual, 2022-12-31) — Total Unusual Items Excluding Goodwill: -1516000.00
CNOB balance_sheet (annual, 2022-12-31) — Treasury Shares Number: 2699026.00
CNOB balance_sheet (annual, 2022-12-31) — Treasury Stock: 52799000.00
CNOB cash_flow (annual, 2022-12-31) — Unrealized Gain Loss On Investment Securities: 1521000.00
CNOB income_statement (annual, 2023-12-31) — +Total Revenue: 269107000.00
CNOB balance_sheet (annual, 2023-12-31) — Accounts Receivable: 49108000.00
CNOB balance_sheet (annual, 2023-12-31) — Accumulated Depreciation: -43177000.00
CNOB balance_sheet (annual, 2023-12-31) — Additional Paid In Capital: 33182000.00
CNOB income_statement (annual, 2023-12-31) — Amortization: 1438000.00
CNOB cash_flow (annual, 2023-12-31) — Amortization Cash Flow: 1438000.00
CNOB cash_flow (annual, 2023-12-31) — Amortization Of Intangibles: 1438000.00
CNOB income_statement (annual, 2023-12-31) — Amortization Of Intangibles Income Statement: 1438000.00
CNOB balance_sheet (annual, 2023-12-31) — Available For Sale Securities: 18564000.00
CNOB income_statement (annual, 2023-12-31) — Basic Average Shares: 38926442.00
CNOB income_statement (annual, 2023-12-31) — Basic EPS: 2.08
CNOB cash_flow (annual, 2023-12-31) — Beginning Cash Position: 268315000.00
CNOB balance_sheet (annual, 2023-12-31) — Buildings And Improvements: 11043000.00
CNOB cash_flow (annual, 2023-12-31) — Capital Expenditure: -7433000.00
CNOB balance_sheet (annual, 2023-12-31) — Capital Lease Obligations: 13171000.00
CNOB balance_sheet (annual, 2023-12-31) — Capital Stock: 697873000.00
CNOB balance_sheet (annual, 2023-12-31) — Cash And Cash Equivalents: 242714000.00
CNOB balance_sheet (annual, 2023-12-31) — Cash Cash Equivalents And Federal Funds Sold: 294171000.00
CNOB cash_flow (annual, 2023-12-31) — Cash Dividends Paid: -31948000.00
CNOB balance_sheet (annual, 2023-12-31) — Cash Financial: 61421000.00
CNOB cash_flow (annual, 2023-12-31) — Cash Flow From Continuing Financing Activities: 129546000.00
CNOB cash_flow (annual, 2023-12-31) — Cash Flow From Continuing Investing Activities: -248038000.00
CNOB cash_flow (annual, 2023-12-31) — Cash Flow From Continuing Operating Activities: 92891000.00
CNOB cash_flow (annual, 2023-12-31) — Change In Other Current Assets: -7514000.00
CNOB cash_flow (annual, 2023-12-31) — Change In Other Current Liabilities: -9248000.00
CNOB cash_flow (annual, 2023-12-31) — Change In Other Working Capital: -54000.00
CNOB cash_flow (annual, 2023-12-31) — Change In Receivables: -3046000.00
CNOB cash_flow (annual, 2023-12-31) — Change In Working Capital: -19862000.00
CNOB cash_flow (annual, 2023-12-31) — Changes In Account Receivables: -3046000.00
CNOB cash_flow (annual, 2023-12-31) — Changes In Cash: -25601000.00
CNOB balance_sheet (annual, 2023-12-31) — Common Stock: 586946000.00
CNOB cash_flow (annual, 2023-12-31) — Common Stock Dividend Paid: -25912000.00
CNOB balance_sheet (annual, 2023-12-31) — Common Stock Equity: 1105693000.00
CNOB cash_flow (annual, 2023-12-31) — Common Stock Payments: -19397000.00
CNOB balance_sheet (annual, 2023-12-31) — Current Debt: 881000000.00
CNOB balance_sheet (annual, 2023-12-31) — Current Debt And Capital Lease Obligation: 881000000.00
CNOB cash_flow (annual, 2023-12-31) — Deferred Income Tax: 4135000.00
CNOB cash_flow (annual, 2023-12-31) — Deferred Tax: 4135000.00
CNOB cash_flow (annual, 2023-12-31) — Depreciation: 4503000.00
CNOB cash_flow (annual, 2023-12-31) — Depreciation Amortization Depletion: 5941000.00
CNOB income_statement (annual, 2023-12-31) — Depreciation Amortization Depletion Income Statement: 1438000.00
CNOB cash_flow (annual, 2023-12-31) — Depreciation And Amortization: 5941000.00
CNOB income_statement (annual, 2023-12-31) — Depreciation And Amortization In Income Statement: 1438000.00
CNOB income_statement (annual, 2023-12-31) — Diluted Average Shares: 39114493.00
CNOB income_statement (annual, 2023-12-31) — Diluted EPS: 2.07
CNOB income_statement (annual, 2023-12-31) — Diluted NI Availto Com Stockholders: 80751000.00
CNOB cash_flow (annual, 2023-12-31) — End Cash Position: 242714000.00
CNOB cash_flow (annual, 2023-12-31) — Financing Cash Flow: 129546000.00
CNOB cash_flow (annual, 2023-12-31) — Free Cash Flow: 85458000.00
CNOB cash_flow (annual, 2023-12-31) — Gain Loss On Investment Securities: 117000.00
CNOB cash_flow (annual, 2023-12-31) — Gain Loss On Sale Of Business: 0.00
CNOB cash_flow (annual, 2023-12-31) — Gain Loss On Sale Of PPE: 0.00
CNOB income_statement (annual, 2023-12-31) — Gain On Sale Of Business: 0.00
CNOB income_statement (annual, 2023-12-31) — Gain On Sale Of Security: -117000.00
CNOB balance_sheet (annual, 2023-12-31) — Gains Losses Not Affecting Retained Earnings: -35109000.00
CNOB income_statement (annual, 2023-12-31) — General And Administrative Expense: 96588000.00
CNOB balance_sheet (annual, 2023-12-31) — Goodwill: 208372000.00
CNOB balance_sheet (annual, 2023-12-31) — Goodwill And Other Intangible Assets: 214246000.00
CNOB balance_sheet (annual, 2023-12-31) — Gross PPE: 85963000.00
CNOB cash_flow (annual, 2023-12-31) — Income Tax Paid Supplemental Data: 31647000.00
CNOB income_statement (annual, 2023-12-31) — Insurance And Claims: 8365000.00
CNOB income_statement (annual, 2023-12-31) — Interest Expense: 234959000.00
CNOB income_statement (annual, 2023-12-31) — Interest Income: 490065000.00
CNOB cash_flow (annual, 2023-12-31) — Interest Paid Supplemental Data: 230806000.00
CNOB balance_sheet (annual, 2023-12-31) — Invested Capital: 2118711000.00
CNOB cash_flow (annual, 2023-12-31) — Investing Cash Flow: -248038000.00
CNOB balance_sheet (annual, 2023-12-31) — Investments And Advances: 635726000.00
CNOB cash_flow (annual, 2023-12-31) — Issuance Of Capital Stock: 0.00
CNOB cash_flow (annual, 2023-12-31) — Issuance Of Debt: 2946500000.00
CNOB balance_sheet (annual, 2023-12-31) — Land And Improvements: 6732000.00
CNOB balance_sheet (annual, 2023-12-31) — Leases: 27633000.00
CNOB balance_sheet (annual, 2023-12-31) — Long Term Capital Lease Obligation: 13171000.00
CNOB balance_sheet (annual, 2023-12-31) — Long Term Debt: 132018000.00
CNOB balance_sheet (annual, 2023-12-31) — Long Term Debt And Capital Lease Obligation: 145189000.00
CNOB cash_flow (annual, 2023-12-31) — Long Term Debt Issuance: 2946500000.00
CNOB cash_flow (annual, 2023-12-31) — Long Term Debt Payments: -2945564000.00